Forte Biosciences is a biopharmaceutical company focused on autoimmune
diseases. Forte’s lead product, FB-102, is a proprietary molecule with potential
as a first-in-class biotherapeutic for the treatment of autoimmune diseases. Our
initial focus will be on Alopecia Areata, Graft-versus-Host Disease (GvHD)/Transplant Rejection and Vitiligo,
large indications with unmet needs. Alopecia Areata is where patches of hair loss occur on the scalp or the body.
Graft-versus-Host Disease (GvHD) is a common potentially life-threatening complication commonly associated with
allogeneic hematopoietic stem cell transplantation. Vitiligo is a chronic disorder that causes patches of skin to
lose pigment or color.